Molecular modeling of lysophosphatidic acid receptor antagonists.

被引：0
|
作者：
Sardar, VM
Virag, T
Fischer, DJ
Elrod, D
Bautista, DL
Wang, DA
Nusser, N
Yokoyama, K
Baker, DL
Miller, DD
Tigyi, G
Parrill, AL
机构：
[1] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
[2] Univ Memphis, Computat Res Mat Inst, Memphis, TN 38152 USA
[3] Univ Tennessee, Dept Physiol & Biophys, Knoxville, TN 37996 USA
[4] Univ Tennessee, Dept Pharmaceut Sci, Knoxville, TN 37996 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
079-MEDI
引用
收藏
页码：U19 / U19
页数：1
相关论文
共 50 条
  • [11] Molecular regulation of lysophosphatidic acid receptor endocytosis and desensitization
    Aziziyeh, Adel Isam
    Pape, Cynthia
    Pampillo, Macarena
    Possmayer, Fred
    Di Guglielmo, John
    Babwah, Andy
    Bhattacharya, Moshmi
    FASEB JOURNAL, 2008, 22
  • [12] Biphenyls as potent vitronectin receptor antagonists.: Part 3:: Squaric acid amides
    Urbahns, Klaus
    Haerter, Michael
    Albers, Markus
    Schmidt, Delf
    Stelte-Ludwig, Beatrix
    Brueggemeier, Ulf
    Vaupel, Andrea
    Keldenich, Joerg
    Lustig, Klemens
    Tsujishita, Hideki
    Gerdes, Christoph
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6151 - 6154
  • [13] Development and therapeutic role of glutamate receptor antagonists.
    Leeson, PD
    Sharp, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 104 - MEDI
  • [14] Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
    Lin, Yu-Hsuan
    Lin, Yueh-Chien
    Chen, Chien-Chin
    CELLS, 2021, 10 (07)
  • [15] Structure activity relationship studies of receptor-selective lysophosphatidic acid antagonists
    Carter, Karen M.
    McCalmont, William F.
    Heasley, Brian H.
    Lynch, Kevin R.
    Macdonald, Timothy L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2741 - U2742
  • [16] 8-oxopurines as CRH receptor antagonists.
    Beck, JP
    Arvanitis, AG
    Cocuzza, AJ
    Chidester, DR
    Curry, MA
    Rescinito, JT
    Fitzgerald, LW
    Zaczek, R
    Calabrese, JC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 94 - MEDI
  • [17] Novel melanin concentrating hormone receptor antagonists.
    Ma, VV
    Balan, C
    Tempest, PA
    Hulme, C
    Bannon, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U67 - U67
  • [18] Discovery of novel human glucagon receptor antagonists.
    Shen, DM
    Zhang, F
    Brady, EJ
    Candelore, MR
    Ding, VDH
    Jiang, G
    Mock, S
    Qureshi, SA
    Saperstein, R
    Tamvakopoulos, C
    Tong, X
    Tota, LM
    Wright, M
    Zheng, S
    Chapman, KT
    Zhang, BB
    Tata, JR
    Parmee, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U121 - U121
  • [19] Receptor binding analysis of cannabinoid agonists and antagonists.
    Thomas, BF
    Gilliam, AF
    Burch, DF
    Roche, MJ
    Seltzman, HH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R49 - R49
  • [20] Discovery of Chemical Scaffolds as Lysophosphatidic Acid Receptor 1 Antagonists: Virtual Screening, In Vitro Validation, and Molecular Dynamics Analysis
    Nguyen, Lan Phuong
    Khan, Rasel Ahmed
    Kang, Soomin
    Lee, Hobin
    Hwang, Jong-Ik
    Kim, Hong-Rae
    ACS OMEGA, 2023, 8 (43): : 40375 - 40386
12345